{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:19:31Z","timestamp":1792405171910,"version":"4.4.0"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T00:00:00Z","timestamp":1708214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.nbd.2024.106442","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T17:04:43Z","timestamp":1708362283000},"page":"106442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["The potential roles of salivary biomarkers in neurodegenerative diseases"],"prefix":"10.1016","volume":"193","author":[{"given":"Ling-Ling","family":"Jiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Lin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Meng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Gao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai-Yuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/scd.12342","article-title":"Evaluation of salivary acetylcholinesterase and pseudocholinesterase in patients with Alzheimer\u2019s disease: a case-control study","volume":"39","author":"Ahmadi-Motamayel","year":"2019","journal-title":"Spec. Care Dentist"},{"issue":"12","key":"10.1016\/j.nbd.2024.106442_bb0010","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4103\/1947-2714.147980","article-title":"Saliva alpha-synuclein and a high extinction coefficient protein: a novel approach in assessment biomarkers of Parkinson\u2019s disease","volume":"6","author":"Al-Nimer","year":"2014","journal-title":"N. Am. J. Med. Sci."},{"key":"10.1016\/j.nbd.2024.106442_bb0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neurobiolaging.2018.06.014","article-title":"No association of salivary total tau concentration with Alzheimer\u2019s disease","volume":"70","author":"Ashton","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2024.106442_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103437","article-title":"Spitting image: can saliva biomarkers reflect Alzheimer's disease?","volume":"68","author":"Ashton","year":"2021","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0025","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1373\/clinchem.2014.230433","article-title":"The landscape of microRNA, Piwi-interacting RNA, and circular RNA in human saliva","volume":"61","author":"Bahn","year":"2015","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0030","article-title":"Can salivary acetylcholinesterase be a diagnostic biomarker for Alzheimer?","volume":"11","author":"Bakhtiari","year":"2017","journal-title":"J. Clin. Diagn. Res."},{"issue":"9","key":"10.1016\/j.nbd.2024.106442_bb0035","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2024.106442_bb0040","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1471-2377-10-108","article-title":"Saliva levels of Abeta1-42 as potential biomarker of Alzheimer\u2019s disease: a pilot study","volume":"10","author":"Bermejo-Pareja","year":"2010","journal-title":"BMC Neurol."},{"key":"10.1016\/j.nbd.2024.106442_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101759","article-title":"Emerging insights between gut microbiome dysbiosis and Parkinson\u2019s disease: pathogenic and clinical relevance","volume":"82","author":"Bi","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"6","key":"10.1016\/j.nbd.2024.106442_bb0050","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/joim.12816","article-title":"Biomarkers for Alzheimer\u2019s disease: current status and prospects for the future","volume":"284","author":"Blennow","year":"2018","journal-title":"J. Intern. Med."},{"issue":"9","key":"10.1016\/j.nbd.2024.106442_bb0055","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrd.2018.109","article-title":"Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing","volume":"17","author":"Boland","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.nbd.2024.106442_bb0060","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/gps.1882","article-title":"Developing a simple laboratory test for Alzheimer\u2019s disease: measuring acetylcholinesterase in saliva - a pilot study","volume":"23","author":"Boston","year":"2008","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"3","key":"10.1016\/j.nbd.2024.106442_bb0065","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2024.106442_bb0070","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neulet.2018.12.030","article-title":"Alpha-synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson\u2019s disease","volume":"696","author":"Cao","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0075","doi-asserted-by":"crossref","first-page":"10175","DOI":"10.1038\/s41598-020-67138-8","article-title":"Human salivary Raman fingerprint as biomarker for the diagnosis of amyotrophic lateral sclerosis","volume":"10","author":"Carlomagno","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2024.106442_bb0080","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev-food-030212-182700","article-title":"The secretion, components, and properties of saliva","volume":"4","author":"Carpenter","year":"2013","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"10.1016\/j.nbd.2024.106442_bb0085","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.dadm.2017.04.002","article-title":"Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin","volume":"8","author":"Carro","year":"2017","journal-title":"Alzheimers Dement. (Amst)"},{"issue":"9","key":"10.1016\/j.nbd.2024.106442_bb0090","doi-asserted-by":"crossref","first-page":"e1267","DOI":"10.1212\/WNL.0000000000010404","article-title":"In vivo distribution of alpha-synuclein in multiple tissues and biofluids in Parkinson disease","volume":"95","author":"Chahine","year":"2020","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.nbd.2024.106442_bb0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cca.2007.04.011","article-title":"Saliva specimen: a new laboratory tool for diagnostic and basic investigation","volume":"383","author":"Chiappin","year":"2007","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.nbd.2024.106442_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10030517","article-title":"Salivary biomarkers of stress, anxiety and depression","volume":"10","author":"Chojnowska","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0105","doi-asserted-by":"crossref","first-page":"7371","DOI":"10.1038\/s41598-018-25095-3","article-title":"Salivary levels of total huntingtin are elevated in Huntington\u2019s disease patients","volume":"8","author":"Corey-Bloom","year":"2018","journal-title":"Sci. Rep."},{"issue":"17","key":"10.1016\/j.nbd.2024.106442_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176363","article-title":"Levels of interleukin-6 in saliva, but not plasma, correlate with clinical metrics in Huntington\u2019s disease patients and healthy control subjects","volume":"21","author":"Corey-Bloom","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.nbd.2024.106442_bb0115","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1113\/jphysiol.1972.sp009721","article-title":"Circadian rhythms in human salivary flow rate and composition","volume":"220","author":"Dawes","year":"1972","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.nbd.2024.106442_bb0120","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.26550","article-title":"A combined panel of salivary biomarkers in de novo Parkinson\u2019s disease","volume":"93","author":"De Bartolo","year":"2023","journal-title":"Ann. Neurol."},{"issue":"5646","key":"10.1016\/j.nbd.2024.106442_bb0125","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1126\/science.1090349","article-title":"Looking backward to move forward: early detection of neurodegenerative disorders","volume":"302","author":"DeKosky","year":"2003","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"Pt 7","key":"10.1016\/j.nbd.2024.106442_bb0135","article-title":"Salivary alpha-synuclein and DJ-1: potential biomarkers for Parkinson's disease","volume":"134","author":"Devic","year":"2011","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.nbd.2024.106442_bb0140","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.4103\/1673-5374.310672","article-title":"Oral frailty and neurodegeneration in Alzheimer\u2019s disease","volume":"16","author":"Dibello","year":"2021","journal-title":"Neural Regen. Res."},{"issue":"10","key":"10.1016\/j.nbd.2024.106442_bb0145","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1176\/ajp.139.10.1350","article-title":"Sialorrhea as a side effect of lithium: a case report","volume":"139","author":"Donaldson","year":"1982","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","article-title":"The Parkinson pandemic-a call to action","volume":"75","author":"Dorsey","year":"2018","journal-title":"JAMA Neurol."},{"issue":"7","key":"10.1016\/j.nbd.2024.106442_bb0155","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028035","article-title":"Pathology of neurodegenerative diseases","volume":"9","author":"Dugger","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"4","key":"10.1016\/j.nbd.2024.106442_bb0160","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/mds.22928","article-title":"Plasma alpha-synuclein in patients with Parkinson\u2019s disease with and without treatment","volume":"25","author":"Duran","year":"2010","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.nbd.2024.106442_bb0165","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1096\/fj.03-1449com","article-title":"Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease","volume":"20","author":"El-Agnaf","year":"2006","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.nbd.2024.106442_bb0170","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033118","article-title":"Clinical neurology and epidemiology of the major neurodegenerative diseases","volume":"10","author":"Erkkinen","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"2","key":"10.1016\/j.nbd.2024.106442_bb0175","first-page":"63","article-title":"Salivary biomarkers for the diagnosis and monitoring of neurological diseases","volume":"41","author":"Farah","year":"2018","journal-title":"Biom. J."},{"key":"10.1016\/j.nbd.2024.106442_bb0180","first-page":"156479","article-title":"Salivary acetylcholinesterase activity is increased in Parkinson's disease: a potential marker of parasympathetic dysfunction","volume":"2015","author":"Fedorova","year":"2015","journal-title":"Parkinsons Dis."},{"issue":"5","key":"10.1016\/j.nbd.2024.106442_bb0185","article-title":"Native alpha-synuclein, 3-nitrotyrosine proteins, and patterns of nitro-alpha-synuclein-immunoreactive inclusions in saliva and submandibulary gland in Parkinson\u2019s disease","volume":"10","author":"Fernandez-Espejo","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"10.1016\/j.nbd.2024.106442_bb0190","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3233\/JPD-202459","article-title":"Oral dysbiosis and inflammation in Parkinson\u2019s disease","volume":"11","author":"Fleury","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.nbd.2024.106442_bb0195","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fnmol.2011.00022","article-title":"Revisiting the role of acetylcholinesterase in Alzheimer\u2019s disease: cross-talk with P-tau and beta-amyloid","volume":"4","author":"Garcia-Ayllon","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2024.106442_bb0200","doi-asserted-by":"crossref","first-page":"103361","DOI":"10.1016\/j.ebiom.2021.103361","article-title":"Lactoferrin in cerebrospinal fluid and saliva is not a diagnostic biomarker for Alzheimer's disease in a mixed memory clinic population","volume":"67","author":"Gleerup","year":"2021","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.nbd.2024.106442_bb0205","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/mds.27232","article-title":"Cerebrospinal fluid, plasma, and saliva in the BioFIND study: relationships among biomarkers and Parkinson\u2019s disease features","volume":"33","author":"Goldman","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2024.106442_bb0210","doi-asserted-by":"crossref","first-page":"102834","DOI":"10.1016\/j.ebiom.2020.102834","article-title":"Decreased salivary lactoferrin levels are specific to Alzheimer's disease","volume":"57","author":"Gonzalez-Sanchez","year":"2020","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0215","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41380-021-01296-7","article-title":"Brain regions susceptible to alpha-synuclein spreading","volume":"27","author":"Guo","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2024.106442_bb0220","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fnmol.2019.00335","article-title":"Evaluation of biochemical and epigenetic measures of peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in Huntington\u2019s disease patients","volume":"12","author":"Gutierrez","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"11","key":"10.1016\/j.nbd.2024.106442_bb0225","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","article-title":"Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic","volume":"14","author":"Hampel","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"10","key":"10.1016\/j.nbd.2024.106442_bb0230","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.nbd.2024.106442_bb0235","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s12264-022-00836-7","article-title":"Biofluid biomarkers of Alzheimer\u2019s disease: progress, problems, and perspectives","volume":"38","author":"Huang","year":"2022","journal-title":"Neurosci. Bull."},{"issue":"4","key":"10.1016\/j.nbd.2024.106442_bb0240","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0896-6273(00)80108-7","article-title":"Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer\u2019s fibrils: possible role of the peripheral site of the enzyme","volume":"16","author":"Inestrosa","year":"1996","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.nbd.2024.106442_bb0245","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1592\/phco.20.1.1.34664","article-title":"Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease","volume":"20","author":"Jann","year":"2000","journal-title":"Pharmacotherapy"},{"issue":"3\u20134","key":"10.1016\/j.nbd.2024.106442_bb0255","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000113679","article-title":"Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia","volume":"5","author":"Jellinger","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.nbd.2024.106442_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.738530","article-title":"Profiling of differentially expressed MicroRNAs in saliva of Parkinson\u2019s disease patients","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2024.106442_bb0265","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neurobiolaging.2021.01.011","article-title":"Early low-dose ghrelin intervention via miniosmotic pumps could protect against the progressive dopaminergic neuron loss in Parkinson\u2019s disease mice","volume":"101","author":"Jiao","year":"2021","journal-title":"Neurobiol. Aging"},{"issue":"11","key":"10.1016\/j.nbd.2024.106442_bb0270","doi-asserted-by":"crossref","first-page":"10749","DOI":"10.1007\/s11033-022-07738-x","article-title":"Role of mitophagy in neurodegenerative diseases and potential tagarts for therapy","volume":"49","author":"Jiao","year":"2022","journal-title":"Mol. Biol. Rep."},{"issue":"14","key":"10.1016\/j.nbd.2024.106442_bb0275","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1523\/JNEUROSCI.5221-09.2010","article-title":"The disintegrin\/metalloproteinase ADAM10 is essential for the establishment of the brain cortex","volume":"30","author":"Jorissen","year":"2010","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.nbd.2024.106442_bb0280","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/ane.12735","article-title":"Cerebrospinal fluid levels of chromogranin A and phosphorylated neurofilament heavy chain are elevated in amyotrophic lateral sclerosis","volume":"136","author":"Kaiserova","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.nbd.2024.106442_bb0285","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fnagi.2014.00102","article-title":"Salivary DJ-1 could be an indicator of Parkinson\u2019s disease progression","volume":"6","author":"Kang","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.nbd.2024.106442_bb0290","doi-asserted-by":"crossref","first-page":"28143","DOI":"10.1038\/srep28143","article-title":"Salivary total alpha-synuclein, oligomeric alpha-synuclein and SNCA variants in Parkinson\u2019s disease patients","volume":"6","author":"Kang","year":"2016","journal-title":"Sci. Rep."},{"issue":"9769","key":"10.1016\/j.nbd.2024.106442_bb0295","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.nbd.2024.106442_bb0300","doi-asserted-by":"crossref","DOI":"10.1117\/1.JBO.19.5.051205","article-title":"Antibody-based magnetic nanoparticle immunoassay for quantification of Alzheimer\u2019s disease pathogenic factor","volume":"19","author":"Kim","year":"2014","journal-title":"J. Biomed. Opt."},{"issue":"2","key":"10.1016\/j.nbd.2024.106442_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117810","article-title":"Non-invasive screening for Alzheimer's disease by sensing salivary sugar using Drosophila cells expressing gustatory receptor (Gr5a) immobilized on an extended gate ion-sensitive field-effect transistor (EG-ISFET) biosensor","volume":"10","author":"Lau","year":"2015","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.nbd.2024.106442_bb0310","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1177\/00220345211014432","article-title":"The human salivary proteome wiki: a community-driven research platform","volume":"100","author":"Lau","year":"2021","journal-title":"J. Dent. Res."},{"issue":"3","key":"10.1016\/j.nbd.2024.106442_bb0315","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3233\/JAD-160748","article-title":"A method for diagnosing Alzheimer\u2019s disease based on salivary amyloid-beta protein 42 levels","volume":"55","author":"Lee","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0320","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13195-020-00696-1","article-title":"Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer\u2019s disease and are highly correlated with phospho-tau in control individuals","volume":"12","author":"Lehmann","year":"2020","journal-title":"Alzheimers Res. Ther."},{"issue":"2","key":"10.1016\/j.nbd.2024.106442_bb0325","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nm.2613","article-title":"Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export","volume":"18","author":"Lei","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2024.106442_bb0330","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.REV120.008207","article-title":"The essential elements of Alzheimer\u2019s disease","volume":"296","author":"Lei","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0335","doi-asserted-by":"crossref","first-page":"9823","DOI":"10.1038\/s41598-021-89168-6","article-title":"Salivary caffeine in Parkinson\u2019s disease","volume":"11","author":"Leodori","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.nbd.2024.106442_bb0340","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.expneurol.2006.12.006","article-title":"Plasma alpha-synuclein is decreased in subjects with Parkinson\u2019s disease","volume":"204","author":"Li","year":"2007","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.nbd.2024.106442_bb0345","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3233\/JAD-190587","article-title":"Analysis of salivary microbiome in patients with Alzheimer\u2019s disease","volume":"72","author":"Liu","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.nbd.2024.106442_bb0350","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/mds.28976","article-title":"Diagnostic value of salivary real-time quaking-induced conversion in Parkinson\u2019s disease and multiple system atrophy","volume":"37","author":"Luan","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2024.106442_bb0355","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1177\/00220345870660S103","article-title":"The functions of saliva","volume":"66 Spec No","author":"Mandel","year":"1987","journal-title":"J. Dent. Res."},{"issue":"10","key":"10.1016\/j.nbd.2024.106442_bb0360","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.parkreldis.2015.07.021","article-title":"Elevated salivary protein in Parkinson\u2019s disease and salivary DJ-1 as a potential marker of disease severity","volume":"21","author":"Masters","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"issue":"4","key":"10.1016\/j.nbd.2024.106442_bb0365","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1152\/physrev.1997.77.4.1081","article-title":"Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives","volume":"77","author":"Mattson","year":"1997","journal-title":"Physiol. Rev."},{"issue":"9","key":"10.1016\/j.nbd.2024.106442_bb0370","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1212\/01.WNL.0000091890.32140.8F","article-title":"Plasma A[beta]40 and A[beta]42 and Alzheimer\u2019s disease: relation to age, mortality, and risk","volume":"61","author":"Mayeux","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0375","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/archneur.57.1.100","article-title":"Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease","volume":"57","author":"Mehta","year":"2000","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0380","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/mco2.1","article-title":"Plasma pTau181 as a biomarker for Alzheimer's disease","volume":"1","author":"Meng","year":"2020","journal-title":"MedComm"},{"issue":"2","key":"10.1016\/j.nbd.2024.106442_bb0385","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group","volume":"11","year":"1996","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0390","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev-anchem-061020-123959","article-title":"Saliva diagnostics","volume":"15","author":"Nonaka","year":"2022","journal-title":"Annu Rev Anal Chem (Palo Alto, Calif)"},{"issue":"21","key":"10.1016\/j.nbd.2024.106442_bb0395","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.2169\/internalmedicine.47.1278","article-title":"Salivary chromogranin A: useful and quantitative biochemical marker of affective state in patients with amyotrophic lateral sclerosis","volume":"47","author":"Obayashi","year":"2008","journal-title":"Intern. Med."},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0400","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s41598-023-28019-y","article-title":"Salivary Huntingtin protein is uniquely associated with clinical features of Huntington\u2019s disease","volume":"13","author":"Parkin","year":"2023","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.nbd.2024.106442_bb0405","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","article-title":"CSF and blood biomarkers for Parkinson\u2019s disease","volume":"18","author":"Parnetti","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2024.106442_bb0410","first-page":"53","article-title":"Development and validation of a salivary tau biomarker in Alzheimer's disease","volume":"11","author":"Pekeles","year":"2019","journal-title":"Alzheimers Dement. (Amst)"},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0415","doi-asserted-by":"crossref","first-page":"16396","DOI":"10.1038\/s41598-020-73362-z","article-title":"Early neurotransmission impairment in non-invasive Alzheimer disease detection","volume":"10","author":"Pena-Bautista","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0420","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/prd.12116","article-title":"The physiology of salivary secretion","volume":"70","author":"Proctor","year":"2016","journal-title":"Periodontol."},{"issue":"6","key":"10.1016\/j.nbd.2024.106442_bb0425","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0197-4580(02)00230-0","article-title":"Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex","volume":"24","author":"Rees","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0430","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.psyneuen.2011.04.013","article-title":"The cortisol awakening response in amyotrophic lateral sclerosis is blunted and correlates with clinical status and depressive mood","volume":"37","author":"Roozendaal","year":"2012","journal-title":"Psychoneuroendocrinology"},{"issue":"7","key":"10.1016\/j.nbd.2024.106442_bb0435","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/01.wnl.0000204230.16619.d9","article-title":"The association of CAG repeat length with clinical progression in Huntington disease","volume":"66","author":"Rosenblatt","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010107","article-title":"Pathogenesis of Alzheimer\u2019s disease","volume":"24","author":"Rostagno","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0445","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12883-018-1160-y","article-title":"Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer\u2019s disease dementia from normal controls: preliminary findings","volume":"18","author":"Sabbagh","year":"2018","journal-title":"BMC Neurol."},{"issue":"2","key":"10.1016\/j.nbd.2024.106442_bb0450","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.clinbiochem.2003.10.007","article-title":"Association of a salivary acetylcholinesterase with Alzheimer\u2019s disease and response to cholinesterase inhibitors","volume":"37","author":"Sayer","year":"2004","journal-title":"Clin. Biochem."},{"issue":"10043","key":"10.1016\/j.nbd.2024.106442_bb0455","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer\u2019s disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"issue":"10284","key":"10.1016\/j.nbd.2024.106442_bb0460","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0465","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s41983-020-0159-7","article-title":"Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson\u2019s disease","volume":"56","author":"Shaheen","year":"2020","journal-title":"Egypt. J. Neurol. Psychiatry Neurosurg."},{"issue":"4","key":"10.1016\/j.nbd.2024.106442_bb0470","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer\u2019s disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0475","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2010.06.009","article-title":"Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson\u2019s disease","volume":"480","author":"Shi","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.nbd.2024.106442_bb0480","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3233\/JAD-2011-110731","article-title":"Salivary tau species are potential biomarkers of Alzheimer\u2019s disease","volume":"27","author":"Shi","year":"2011","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.nbd.2024.106442_bb0485","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.22311","article-title":"Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression","volume":"69","author":"Shi","year":"2011","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.nbd.2024.106442_bb0490","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF01677425","article-title":"Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer\u2019s disease","volume":"75","author":"Sirvio","year":"1989","journal-title":"J. Neural Transm."},{"issue":"6","key":"10.1016\/j.nbd.2024.106442_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065237","article-title":"Saliva and saliva extracellular vesicles for biomarker candidate identification-assay development and pilot study in amyotrophic lateral sclerosis","volume":"24","author":"Sjoqvist","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.nbd.2024.106442_bb0500","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/mds.27328","article-title":"Evaluation of salivary heme oxygenase-1 as a potential biomarker of early Parkinson\u2019s disease","volume":"33","author":"Song","year":"2018","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.nbd.2024.106442_bb0505","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1750-3639.2009.00371.x","article-title":"Pathologic correlates of dementia in individuals with Lewy body disease","volume":"20","author":"Sonnen","year":"2010","journal-title":"Brain Pathol."},{"issue":"5","key":"10.1016\/j.nbd.2024.106442_bb0510","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2174\/156720510791383796","article-title":"The cerebrospinal fluid amyloid beta42\/40 ratio in the differentiation of Alzheimer\u2019s disease from non-Alzheimer\u2019s dementia","volume":"7","author":"Spies","year":"2010","journal-title":"Curr. Alzheimer Res."},{"issue":"2","key":"10.1016\/j.nbd.2024.106442_bb0515","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.neurobiolaging.2013.08.008","article-title":"Cheek cell-derived alpha-synuclein and DJ-1 do not differentiate Parkinson\u2019s disease from control","volume":"35","author":"Stewart","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.nbd.2024.106442_bb0520","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/s13311-023-01382-4","article-title":"Inhibition of ACSL4 alleviates parkinsonism phenotypes by reduction of lipid reactive oxygen species","volume":"20","author":"Tang","year":"2023","journal-title":"Neurotherapeutics"},{"issue":"12","key":"10.1016\/j.nbd.2024.106442_bb0525","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMra021405","article-title":"The chromogranin-secretogranin family","volume":"348","author":"Taupenot","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0530","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0024-3205(96)00583-8","article-title":"Oxidative-stress associated parameters (lactoferrin, superoxide dismutases) in serum of patients with Alzheimer\u2019s disease","volume":"60","author":"Thome","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.nbd.2024.106442_bb0535","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.2147\/IJN.S200490","article-title":"Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics","volume":"14","author":"Tiwari","year":"2019","journal-title":"Int. J. Nanomedicine"},{"issue":"5","key":"10.1016\/j.nbd.2024.106442_bb0540","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson\u2019s disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.nbd.2024.106442_bb0545","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1007\/s00784-020-03214-7","article-title":"Salivary biomarkers in Alzheimer\u2019s disease","volume":"24","author":"Tvarijonaviciute","year":"2020","journal-title":"Clin. Oral Investig."},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0550","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nn1603","article-title":"Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis","volume":"9","author":"Urushitani","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2024.106442_bb0555","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neurobiolaging.2018.02.017","article-title":"Chromogranin A levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"67","author":"Verde","year":"2018","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.nbd.2024.106442_bb0560","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2024.106442_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151156","article-title":"Abnormal salivary total and oligomeric alpha-synuclein in Parkinson\u2019s disease","volume":"11","author":"Vivacqua","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2024.106442_bb0570","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.parkreldis.2019.02.014","article-title":"Salivary alpha-synuclein in the diagnosis of Parkinson\u2019s disease and progressive supranuclear palsy","volume":"63","author":"Vivacqua","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0575","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/mds.29246","article-title":"Salivary alpha-Synuclein RT-QuIC correlates with disease severity in de novo Parkinson\u2019s disease","volume":"38","author":"Vivacqua","year":"2023","journal-title":"Mov. Disord."},{"issue":"9557","key":"10.1016\/j.nbd.2024.106442_bb0580","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.nbd.2024.106442_bb0585","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/gps.4053","article-title":"The efficacy of plasma biomarkers in early diagnosis of Alzheimer\u2019s disease","volume":"29","author":"Wang","year":"2014","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"3","key":"10.1016\/j.nbd.2024.106442_bb0590","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.bbrc.2006.05.011","article-title":"Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson\u2019s disease","volume":"345","author":"Waragai","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.nbd.2024.106442_bb0595","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neulet.2007.08.010","article-title":"Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson\u2019s disease","volume":"425","author":"Waragai","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"10","key":"10.1016\/j.nbd.2024.106442_bb0600","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1172\/JCI64565","article-title":"Mutant huntingtin fragmentation in immune cells tracks Huntington\u2019s disease progression","volume":"122","author":"Weiss","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.nbd.2024.106442_bb0605","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1172\/JCI80743","article-title":"Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington\u2019s disease patients","volume":"125","author":"Wild","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.nbd.2024.106442_bb0610","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202300285","article-title":"Diagnosis of Parkinson\u2019s disease via the metabolic fingerprint in saliva by deep learning","volume":"7","author":"Xu","year":"2023","journal-title":"Small Methods"},{"issue":"2","key":"10.1016\/j.nbd.2024.106442_bb0615","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3233\/JAD-161226","article-title":"Diagnostic biomarkers of Alzheimer\u2019s disease as identified in saliva using 1H NMR-based metabolomics","volume":"58","author":"Yilmaz","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.nbd.2024.106442_bb0620","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ijos.2016.38","article-title":"Saliva in the diagnosis of diseases","volume":"8","author":"Zhang","year":"2016","journal-title":"Int. J. Oral Sci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999612400041X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999612400041X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:48:10Z","timestamp":1725583690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999612400041X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":124,"alternative-id":["S096999612400041X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2024.106442","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential roles of salivary biomarkers in neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2024.106442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106442"}}